IUPAC/Chemical Name
2,6-Di-tert-butyl-4-(3-(3-pyridylmethoxy)propyl)phenol
InChi Key
YNBBIPPQHYZTQF-UHFFFAOYSA-N
InChi Code
InChI=1S/C23H33NO2/c1-22(2,3)19-13-17(14-20(21(19)25)23(4,5)6)10-8-12-26-16-18-9-7-11-24-15-18/h7,9,11,13-15,25H,8,10,12,16H2,1-6H3
SMILES Code
OC1=C(C(C)(C)C)C=C(CCCOCC2=CC=CN=C2)C=C1C(C)(C)C
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
355.52
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Lupp A, Kerst S, Karge E, Quack G, Klinger W. Investigation on possible antioxidative properties of the NMDA-receptor antagonists ketamine, memantine, and amantadine in comparison to nicanartine in vitro. Exp Toxicol Pathol. 1998 Sep;50(4-6):501-6. PubMed PMID: 9784030.
2: Dailly E, Urien S, Wülfroth P, Tillement JP. Nicanartine improves in vitro resistance of lipoproteins to oxidation. Pharm Res. 1996 Mar;13(3):457-61. PubMed PMID: 8692742.
3: Hammes HP, Bartmann A, Engel L, Wülfroth P. Antioxidant treatment of experimental diabetic retinopathy in rats with nicanartine. Diabetologia. 1997 Jun;40(6):629-34. PubMed PMID: 9222640.
4: Wohlfrom M, Hanke S, Kamenz J, Voisard R, Heise N, Seibold W, Lenz C, Quack G, Wühlfroth P, Hanke H. Effect of the antioxidant Nicanartine on the proliferative and inflammatory response after experimental balloon angioplasty. Coron Artery Dis. 1998;9(12):831-7. PubMed PMID: 9894928.
5: Heinle H, Wülfroth P, Quack G, Lang F. Effects of the new antioxidant nicanartine in an experimental model of atherosclerosis. Arzneimittelforschung. 1996 Oct;46(10):956-9. PubMed PMID: 8931887.
6: Dailly E, Urien S, Tillement JP. Chain-breaking antioxidants and ferriheme-bound drugs are synergistic inhibitors of erythrocyte membrane peroxidation. Free Radic Res. 1998 Feb;28(2):205-14. PubMed PMID: 9645396.
7: Dailly E. [Study of lipid peroxidation inhibition in human blood by several endogenous and exogenous compounds]. Ann Pharm Fr. 2000 Oct;58(5):303-7. French. PubMed PMID: 11060406.
